| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crispr Therapeutics AG (CRSP) has 7 insiders with recent SEC Form 4 filings, including 6 buys and 13 sells. CRSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $13.89M | - | |
| Dir | 22.0K | $1.20M | - | |
| CFO | 19.5K | $1.06M | - | |
| Other | 19.4K | $1.05M | -3,786 | |
| Other | 17.0K | $924.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 11, 2019 | Klein Lawrence Otto | Chief Business Officer | Sale+OE | 20,000 | $50.02 | $1,000,352.84 | -33.3% | |
| Jul 10, 2019 | Novak Rodger75 | President | Sell | 50,000 | $50.00 | $2,500,065.00 | -5.6% | |
| Jun 17, 2019 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 20,000 | $46.00 | $920,000.00 | -10.8% | |
| Jun 10, 2019 | Novak Rodger75 | President | Sell | 50,000 | $45.00 | $2,250,000.00 | -5.3% | |
| Apr 29, 2019 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 20,000 | $42.03 | $840,600.00 | -10.7% | |
| Mar 4, 2019 | Novak Rodger75 | President | Sell | 85,220 | $40.40 | $3,443,036.71 | -2.1% | |
| Feb 25, 2019 | Novak Rodger75 | President | Sell | 14,780 | $40.00 | $591,232.52 | -1.4% | |
| Jan 9, 2019 | Novak Rodger75 | President | Sell | 100,000 | $35.02 | $3,502,384.80 | -4.4% | |
| Dec 27, 2018 | Vertex Pharmaceuticals (europe) Ltd | 10% Owner | Buy | 40,198 | $24.93 | $1,002,193.68 | +0.4% | |
| Dec 24, 2018 | Vertex Pharmaceuticals (europe) Ltd | 10% Owner | Buy | 90,742 | $24.08 | $2,184,960.17 | +0.4% |